932 / 1983
NCT00004054
RTOG-9902: Int J Radiat Oncol Biol Phys. 2015 Oct 1;93(2):294-302
Primary endpoint: 5-year OS
Random
RT 70.2 Gy(RBE)+ ADT 24 m.
RT 79.2 Gy(RBE) + ADT 24 m.
+
paclitaxel, estramustine, and oral
etoposide
No significant differences in OS, biochemical failure, local progression,
distant metastases, or disease-free survival
with the addition of adjuvant CT to LT AS þ RT.